Rockwell Medical (RMTI) Net Cash Flow Growth (5y) (2015 - 2026)
Rockwell Medical (RMTI) Net Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.98% |
| Mar 31, 2026 | 38.60% |
| Dec 31, 2025 | 18.01% |
| Sep 30, 2025 | -48.49% |
| Jun 30, 2025 | 16.06% |
| Mar 31, 2025 | -16.73% |
| Dec 31, 2024 | 26.71% |
| Sep 30, 2024 | 15.64% |
| Jun 30, 2024 | 60.04% |
| Mar 31, 2024 | -5.46% |
| Dec 31, 2023 | -41.87% |
| Sep 30, 2023 | -19.83% |
| Jun 30, 2023 | -4.80% |
| Mar 31, 2023 | 16.60% |
| Dec 31, 2022 | -21.40% |
| Sep 30, 2022 | -31.21% |
| Jun 30, 2022 | 80.35% |
| Mar 31, 2022 | 8.36% |
| Dec 31, 2021 | -36.77% |
| Sep 30, 2021 | -14.70% |